Biologics Don't Forgive a Broken Cold Chain: What Travellers on Adalimumab and Infliximab Must Know

A single hour above 8°C can silently degrade your biologic. Here's how to protect adalimumab, infliximab, and other autoimmune injectables across borders.

Biologics don't forgive a broken cold chain: what you need to know

Adalimumab degrades measurably after cumulative exposure above 8°C exceeding 14 days^[1], and there is no visual sign of that degradation. The pen looks identical. The liquid looks clear. You would have no way of knowing until your disease activity climbs weeks after the dose.

That is the specific risk that makes biologics different from almost every other medication travellers carry. Most drugs tolerate a warm bag for a few hours. Monoclonal antibodies do not.This guide covers anti-TNF biologics for IBD, rheumatoid arthritis, and related autoimmune conditions. For insulin and refrigerated medication generally see our insulin and cold-chain guide, CGRP biologics guide, and biologic asthma medication guide.

Medical disclaimer: This article is for general informational purposes and does not constitute medical advice. Regulations, drug availability, and storage requirements change. Always consult your prescribing specialist and check official health authority guidance for your destination before you travel.

What the cold chain actually means for a biologic

Adalimumab (Humira, Hyrimoz, Imraldi) and infliximab (Remicade, Inflectra, Remsima) are both licensed for storage between 2°C and 8°C^[2]. The 2°C floor matters as much as the ceiling: freezing destroys the protein structure just as effectively as heat.

Adalimumab has a published excursion window: up to 14 days at room temperature (up to 25°C)^[3] before it must be used or discarded. This buffer exists, but it is a one-time allowance, not a repeatable margin. Once you use it, it is gone.

Infliximab is more complex because it is typically administered as an infusion in a clinical setting. Travellers do not usually carry it themselves. The cold-chain risk for infliximab falls on the receiving hospital or infusion centre, which is a different planning problem.

Where the cold chain actually breaks for travellers

The aircraft hold problem. Baggage holds on commercial aircraft are not temperature-controlled in the same way as passenger cabins. They can drop well below 0°C on long-haul flights. Freezing adalimumab is as damaging as overheating it. Keep your biologics in carry-on luggage.

The hotel minibar problem. Minibars cycle between cold and off depending on guest usage and hotel energy management. The temperature inside fluctuates. A fridge that feels cold to the touch may be running at 12°C or dropping to near-freezing overnight. A compact medical cooler with a data logger is more reliable.

The customs delay problem. Crossing a border with biological medicines draws scrutiny. If customs hold your bag while you wait in a secondary queue for an hour in a warm inspection room, that counts against your excursion window. Having documentation ready reduces delay time.

The destination pharmacy problem. If you need to source a replacement dose abroad, biosimilar availability varies sharply by country. The biosimilar approved in your home country may not be registered in your destination. Brand substitution is not straightforward with biologics.

What to carry and how to pack it

A purpose-built cold-chain medication travel case is not optional for trips longer than a day. Frio cooling wallets use water-activated crystals and keep contents between 18°C and 26°C, which is within the excursion window for adalimumab but not a substitute for refrigeration on multi-week trips. Medical-grade electric coolers such as the Dometic CFX or 4AllFamily models maintain 2°C to 8°C actively and run from USB power banks or car sockets.

Add a USB temperature data logger. Devices like the Elitech RC-5 record every temperature reading at set intervals, typically every 30 minutes. If your medication is challenged at a pharmacy or clinic abroad, you can show an unbroken temperature record. If you discover a temperature excursion, you have documented evidence for your insurer or prescriber.

Pack a minimum of one extra dose beyond your scheduled supply. Delays happen. A dose left behind in a defective hotel fridge should not leave you without cover. Most prescribers will provide a prescription for additional supply when you explain travel requirements.

Documentation that prevents a border seizure

IATA's dangerous goods regulations exempt personal medical supplies from most hazmat restrictions^[4], but individual country customs authorities set their own import rules for biological medicines. Some require a doctor's letter. Some require import permits. A handful, including Japan, require an advance import notification called a Yunyu Kakunin-sho for prescription medicines brought in quantities above a one-month supply.

At minimum, carry a signed letter from your prescribing physician on clinic letterhead. The letter should state your diagnosis, the generic and brand name of the biologic, the dose, the frequency, and the quantity you are carrying. Understanding medication import rules for your specific destination before you travel saves significant delays at the border.

Keep medication in its original manufacturer packaging with the pharmacy label intact. Repackaging into smaller containers to save space removes the batch number and expiry date, both of which customs officials and pharmacists abroad need to verify the product.

Arranging infliximab infusions abroad

If your dosing interval falls during a trip, you have two options: shift the dose before departure with your specialist's agreement, or arrange an infusion centre abroad. Both require lead time of at least six to eight weeks.

Private infusion centres exist in most major cities. Costs vary considerably. In Thailand, a private infusion session at a hospital such as Bumrungrad typically costs ฿3,000 to ฿8,000 (~$82 to ~$218 / ~€75 to ~€200) for the administration fee, excluding the drug cost itself. The drug must usually be sourced separately and brought by the patient, since hospitals cannot guarantee imported biosimilar compatibility^[5] without prior approval.

Confirm in writing that the infusion centre will accept an externally supplied drug. Get the confirmation before you travel, not on arrival. Some centres refuse liability for drugs not procured through their own pharmacy.

Travel insurance and biologics: what most policies exclude

Standard travel insurance policies classify biologic therapy as a pre-existing condition^[6]. A flare managed with your regular biologic dose is typically excluded. Emergency hospitalisation caused by a flare, however, may be covered if you declared your condition at policy inception.

The distinction between a pre-existing condition claim and an unrelated emergency claim is where disputes arise. Read the policy wording carefully before purchase. Specialist policies that explicitly cover pre-existing conditions exist, but they require medical underwriting at the point of purchase. Standard annual policies typically do not include this cover.

No standard policy covers replacement medication costs if your biologics are lost, stolen, or destroyed by a temperature excursion. Some policies cover emergency medication, but biologics are almost never included in that category due to cost. Replacement adalimumab pricing varies widely abroad — biosimilars in some EU markets retail under €100 per pen, while originator Humira at private pharmacies in countries without biosimilar competition can exceed €500 (~$590) per pen.

What your medical record needs to contain before you board

An emergency physician abroad who does not know you are on a biologic may prescribe NSAIDs or corticosteroids at doses that interact with your immunosuppression. The International Patient Summary standard^[7] is designed specifically for this scenario: a structured, machine-readable record that any clinician in any country can open and read immediately, with your active medications listed by INN generic name.

Your IPS should list your biologic by its INN name (adalimumab, not Humira), your dose, your frequency, and your underlying diagnosis code. It should also flag any previous adverse reactions to biosimilar switches. Nomedic lets you build and carry this record in the IPS format, accessible offline and shareable with a treating team in seconds.

A practical pre-departure checklist

Confirm your dose timing. If your injection date falls within three days of departure or during travel, ask your specialist whether shifting the dose by up to one week in either direction is clinically acceptable.

Obtain a prescription for an extra dose. One additional unit beyond your travel supply is the standard recommendation for trips over seven days.

Purchase a validated medical cooler and a data logger. Test both at home before you travel. Replace ice packs or recharge the battery the night before departure.

Request a physician letter on clinic letterhead. Include the INN generic name, brand name, dose, quantity, and your diagnosis. Carry a digital copy and a printed copy.

Check destination import rules. Contact the destination country's health authority or embassy. Many countries permit personal supplies of up to 30 days without additional permits. Quantities above that threshold may require advance approval.

Update your IPS. Confirm your biologic, dose, and underlying condition are current. Share the record QR code with a travel companion so it is accessible even if your phone is unavailable.

Frequently asked questions

Can I carry adalimumab in my hand luggage on a flight?

Yes. Keep adalimumab in carry-on luggage, not checked baggage, to avoid freezing temperatures in the hold. Carry a signed physician letter confirming it is prescribed medicine. Most airport security authorities follow IATA guidance permitting medical liquids in quantities exceeding the standard 100 ml limit when accompanied by documentation.

What happens if my biologic is accidentally frozen?

Freezing denatures the protein structure and renders the medication ineffective or potentially immunogenic. Do not use a biologic that has been frozen unless your prescriber or the manufacturer's medical information line specifically confirms safety after reviewing the exposure details. Contact your specialist immediately.

How do I find an infusion centre abroad for infliximab?

Contact a private hospital in your destination city at least six to eight weeks before travel. Ask specifically whether they will administer a biologic supplied by the patient, and request written confirmation. Your home specialist may also have a referral network or can write a formal referral letter to facilitate the arrangement.

Will travel insurance cover a biologic that spoils during travel?

Standard travel insurance policies almost never cover replacement biologic medication costs. Some specialist policies cover emergency medication, but biologics are typically excluded due to high unit cost. Review the policy exclusions section specifically before purchasing cover.

Is the biosimilar version of my biologic available everywhere?

No. Biosimilar registration is country-specific. A biosimilar approved in one country may not be registered in your destination. If you need a replacement dose abroad, contact the manufacturer's country office or a local specialist directly, as brand availability varies significantly.